Literature DB >> 24523508

Regulation of MHC class I expression by Foxp3 and its effect on regulatory T cell function.

Jie Mu1, Xuguang Tai, Shankar S Iyer, Jocelyn D Weissman, Alfred Singer, Dinah S Singer.   

Abstract

Expression of MHC class I molecules, which provide immune surveillance against intracellular pathogens, is higher on lymphoid cells than on any other cell types. In T cells, this is a result of activation of class I transcription by the T cell enhanceosome consisting of Runx1, CBFβ, and LEF1. We now report that MHC class I transcription in T cells also is enhanced by Foxp3, resulting in higher levels of class I in CD4(+)CD25(+) T regulatory cells than in conventional CD4(+)CD25(-) T cells. Interestingly, the effect of Foxp3 regulation of MHC class I transcription is cell type specific: Foxp3 increases MHC class I expression in T cells but represses it in epithelial tumor cells. In both cell types, Foxp3 targets the upstream IFN response element and downstream core promoter of the class I gene. Importantly, expression of MHC class I contributes to the function of CD4(+)CD25(+) T regulatory cells by enhancing immune suppression, both in in vitro and in vivo. These findings identify MHC class I genes as direct targets of Foxp3 whose expression augments regulatory T cell function.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24523508      PMCID: PMC3952169          DOI: 10.4049/jimmunol.1302847

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

2.  CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II.

Authors:  Charalambos Spilianakis; Androniki Kretsovali; Theodora Agalioti; Takis Makatounakis; Dimitris Thanos; Joseph Papamatheakis
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 3.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Cross-linking of MHC class I molecules on human NK cells inhibits NK cell function, segregates MHC I from the NK cell synapse, and induces intracellular phosphotyrosines.

Authors:  Gonzalo Rubio; Xavier Férez; María Sánchez-Campillo; Jesús Gálvez; Salvador Martí; Rocío Verdú; Trinidad Hernández-Caselles; Pilar García-Peñarrubia
Journal:  J Leukoc Biol       Date:  2004-05-03       Impact factor: 4.962

5.  Identification of regulatory elements associated with a class I MHC gene.

Authors:  D S Singer; R Ehrlich
Journal:  Curr Top Microbiol Immunol       Date:  1988       Impact factor: 4.291

6.  MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?

Authors:  Nabila Jabrane-Ferrat; Nada Nekrep; Giovanni Tosi; Laura Esserman; B Matija Peterlin
Journal:  Int Immunol       Date:  2003-04       Impact factor: 4.823

7.  Characterization of a porcine genomic clone encoding a major histocompatibility antigen: expression in mouse L cells.

Authors:  D S Singer; R D Camerini-Otero; M L Satz; B Osborne; D Sachs; S Rudikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus.

Authors:  E Mozes; L D Kohn; F Hakim; D S Singer
Journal:  Science       Date:  1993-07-02       Impact factor: 47.728

9.  Expression of a microinjected porcine class I major histocompatibility complex gene in transgenic mice.

Authors:  W I Frels; J A Bluestone; R J Hodes; M R Capecchi; D S Singer
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

10.  MHC class I gene expression is negatively regulated by the proto-oncogene, c-jun.

Authors:  T K Howcroft; J C Richardson; D S Singer
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  9 in total

1.  Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.

Authors:  Tess O'Meara; Anton Safonov; David Casadevall; Tao Qing; Andrea Silber; Brigid Killelea; Christos Hatzis; Lajos Pusztai
Journal:  Breast Cancer Res Treat       Date:  2019-02-06       Impact factor: 4.872

2.  Immune phenotype of the CD4+ T cells in the aged lymphoid organs and lacrimal glands.

Authors:  Claudia M Trujillo-Vargas; Kelsey E Mauk; Humberto Hernandez; Rodrigo G de Souza; Zhiyuan Yu; Jeremias G Galletti; Jana Dietrich; Friedrich Paulsen; Cintia S de Paiva
Journal:  Geroscience       Date:  2022-03-12       Impact factor: 7.713

3.  Dynamic Frequency of Blood CD4+CD25+ Regulatory T Cells in Rats with Collagen-induced Arthritis.

Authors:  Tingyu Wang; Jun Li; Zhigui Jin; Feihua Wu; Yunwu Li; Xiaohua Wang; Hong Zhou; Qian Zhou
Journal:  Korean J Physiol Pharmacol       Date:  2015-02-25       Impact factor: 2.016

Review 4.  The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer.

Authors:  Manel B Hammouda; Amy E Ford; Yuan Liu; Jennifer Y Zhang
Journal:  Cells       Date:  2020-04-02       Impact factor: 6.600

5.  TSC1/mTOR-controlled metabolic-epigenetic cross talk underpins DC control of CD8+ T-cell homeostasis.

Authors:  Lei Shi; Xia Chen; Aiping Zang; Tiantian Li; Yanxiang Hu; Shixin Ma; Mengdie Lü; Huiyong Yin; Haikun Wang; Xiaoming Zhang; Bei Zhang; Qibin Leng; Jinbo Yang; Hui Xiao
Journal:  PLoS Biol       Date:  2019-08-21       Impact factor: 8.029

6.  Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy.

Authors:  Rajasekharan Somasundaram; Thomas Connelly; Robin Choi; Hyeree Choi; Anastasia Samarkina; Ling Li; Elizabeth Gregorio; Yeqing Chen; Rohit Thakur; Mohamed Abdel-Mohsen; Marilda Beqiri; Meaghan Kiernan; Michela Perego; Fang Wang; Min Xiao; Patricia Brafford; Xue Yang; Xiaowei Xu; Anthony Secreto; Gwenn Danet-Desnoyers; Daniel Traum; Klaus H Kaestner; Alexander C Huang; Denitsa Hristova; Joshua Wang; Mizuho Fukunaga-Kalabis; Clemens Krepler; Fang Ping-Chen; Xiangyang Zhou; Alexis Gutierrez; Vito W Rebecca; Prashanthi Vonteddu; Farokh Dotiwala; Shashi Bala; Sonali Majumdar; Harsh Dweep; Jayamanna Wickramasinghe; Andrew V Kossenkov; Jorge Reyes-Arbujas; Kenisha Santiago; Tran Nguyen; Johannes Griss; Frederick Keeney; James Hayden; Brian J Gavin; David Weiner; Luis J Montaner; Qin Liu; Lukas Peiffer; Jürgen Becker; Elizabeth M Burton; Michael A Davies; Michael T Tetzlaff; Kar Muthumani; Jennifer A Wargo; Dmitry Gabrilovich; Meenhard Herlyn
Journal:  Nat Commun       Date:  2021-01-12       Impact factor: 14.919

7.  Cancer and Autoimmune Diseases: A Tale of Two Immunological Opposites?

Authors:  Zeev Elkoshi
Journal:  Front Immunol       Date:  2022-01-25       Impact factor: 7.561

Review 8.  Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers.

Authors:  Joe Abdo; David L Cornell; Sumeet K Mittal; Devendra K Agrawal
Journal:  Front Oncol       Date:  2018-03-28       Impact factor: 6.244

9.  Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells.

Authors:  Shalini Sethumadhavan; Murillo Silva; Phaethon Philbrook; Thao Nguyen; Stephen M Hatfield; Akio Ohta; Michail V Sitkovsky
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.